Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 135,247 |
|
|||||
| News | (2) | ||||||
| Day High | 2.01 | Low High |
|||||
| Day Low | 1.8655 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Context Therapeutics Inc | CNTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.04 | -2.03% | 1.93 | 23:00:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.97 | 1.8655 | 2.01 | 1.96 | 1.97 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,098 | 135,247 | US$ 1.96 | US$ 264,749 | - | 0.77 - 2.24 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:27:14 | formt | 223 | US$ 1.93 | USD |
Context Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 31.29M | 15.97M | - | 0 | -23.96M | -1.50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Context Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.74 | 2.24 | 1.64 | 1.98 | 263,388 | 0.19 | 10.92% |
| 1 Month | 1.84 | 2.24 | 1.352 | 1.96 | 207,635 | 0.09 | 4.89% |
| 3 Months | 1.09 | 2.24 | 1.08 | 1.76 | 640,600 | 0.84 | 77.06% |
| 6 Months | 0.95 | 2.24 | 0.835 | 1.70 | 325,687 | 0.98 | 103.16% |
| 1 Year | 1.24 | 2.24 | 0.77 | 1.65 | 181,791 | 0.69 | 55.65% |
| 3 Years | 4.44 | 10.87 | 0.47 | 3.81 | 833,590 | -2.51 | -56.53% |
| 5 Years | 4.44 | 10.87 | 0.47 | 3.81 | 833,590 | -2.51 | -56.53% |
Context Therapeutics Description
| Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. |
